U.S., March 3 -- ClinicalTrials.gov registry received information related to the study (NCT07442097) titled 'Safe-Age Study: A Safety and Tolerability Study of a Nutritional Supplement in Healthy Older Adults' on Feb. 08.
Brief Summary: The goal of this clinical trial is to evaluate the safety and tolerability of the nutritional supplement Youniqor in healthy older adults. The main questions it aims to answer are:
Is Youniqor safe and well tolerated when taken daily by healthy adults aged 60 to 80 years? Are there any adverse events or clinically relevant changes in vital signs or laboratory parameters during the study period?
Participants will:
Take Youniqor daily for 8 weeks Attend scheduled study visits for safety assessments, includ...